Binimetinib
Back to searchMolecule Structure
Scientific Name
Binimetinib
Description of the Drug
Binimetinib is a medication used to treat metastatic melanoma with specific mutations.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11967
http://www.drugbank.ca/drugs/DB11967
Brand Name(s)
Mektovi
Company Owner(s)
Array Biopharma Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dual specificity mitogen-activated protein kinase kinase 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL3587 |
| Dual specificity mitogen-activated protein kinase kinase 2 | SINGLE PROTEIN | INHIBITOR | CHEMBL2964 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL570088 | |
| PharmGKB | PA166179867 | |
| Human Metabolome Database | HMDB0304890 | |
| DrugBank | DB11967 | |
| PubChem: Thomson Pharma | 15294150 | |
| PubChem | 10288191 | |
| LINCS | LSM-45640 | |
| Nikkaji | J3.336.515B | |
| PDBe | QO7 | |
| EPA CompTox Dashboard | DTXSID70209422 | |
| DrugCentral | 5290 | |
| Brenda | 217811 | |
| ChemicalBook | CB82604200 | |
| Guide to Pharmacology | 7921 | |
| rxnorm | MEKTOVI | BINIMETINIB |
| ChEBI | 145371 | |
| ZINC | ZINC000038460704 |
